
Nirmal Vasant Mulye
About Nirmal Vasant Mulye
Data last updated:
Nirmal Vasant Mulye was a Director at Pen&Paper Creative Content Private Limited (2019–2025), Director at Bombay Bio-Research Centre Private Limited (2011–2025) and Director at Nostrum Technologies Private Limited (2007–2025), and held 3 more directorships. The companies operate in Media and Publishing, Life Sciences and Information Technology.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Dec 2019 | 2019 | Active | ||
| Director | 20 Dec 2011 | 2011 | ₹35,170 (FY 2023) | Active | |
| Director | 01 Oct 2007 | 2007 | ₹21,450 (FY 2022) | Active | |
| Director | 15 Feb 2019 | 2019 | ₹58.9 Lakh (FY 2024) | Active | |
| Director | 16 Jun 2009 | 2007 | ₹5.5 Lakh (FY 2025) | Active | |
| Director | 14 Aug 2001 | 2001 | ₹42.33 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirmal Vasant Mulye
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirmal Vasant Mulye
Nirmal Vasant Mulye was first appointed on 14 Aug 2001 as Director at Enem Nostrum Remedies Private Limited. The most recent appointment on record is 18 Dec 2019 at Pen&Paper Creative Content Private Limited.
Nirmal Vasant Mulye held 6 earlier board appointments: Pen&Paper Creative Content Private Limited (Director, 18 Dec 2019 to 28 Aug 2025); Bombay Bio-Research Centre Private Limited (Director, 20 Dec 2011 to 01 Sep 2025); Nostrum Technologies Private Limited (Director, 01 Oct 2007 to 01 Sep 2025); Nli Healthcare (India) Private Limited (Director, 15 Feb 2019 to 01 Sep 2025); Symmetrix Biotech Private Limited (Director, 16 Jun 2009 to 01 Sep 2025); and 1 more.